Milella Michele S, Della Grotta Giada, Razafimpanana Nirinalisera, Marinelli Cristiano, Eugelio Fabiola, Fanti Federico, Oliva Eleonora, Sergi Manuel, Pugliese Francesco, Galardo Gioacchino, Vivino Gabriella, Caprioli Daniele
Poison Control Centre Unit - Policlinico Umberto I Hospital-Sapienza University, viale del Policlinico 155, 00185, Rome, Italy.
Medical Emergency Unit - Policlinico Umberto I-Sapienza University, viale del Policlinico 155, 00185, Rome, Italy.
Toxicon. 2025 Mar;256:108268. doi: 10.1016/j.toxicon.2025.108268. Epub 2025 Jan 30.
Yellow oleander contains digoxin-like cardiac glycosides that frequently cause intoxications in Sri Lanka and India. To date, though, no exposure has been analytically confirmed and quantitative determination of the plant specific glycosides in human biological fluids was never performed. We report an unusual case of self-poisoning in a young female in Italy who ingested 9 crushed seeds of Cascabela thevetia and was admitted to the emergency room with a 2nd degree atrio-ventricular block at the ECG. The case was managed with activated charcoal, repeated doses of anti-digoxin immune Fab and supportive care. A transient thrombocytopenia developed and resolved within a few days. Ultra-high performance liquid chromatography coupled with tandem mass spectrometry was used for the determination and quantification of thevetin A, thevetin B and peruvoside in plasma and urine. Thevetin A and thevetin B, two of the primary glycosides in the seeds, were not present in any of the samples, while detectable levels of the metabolite peruvoside were found in all biological samples on day 1 and 3. Digitoxigenin, the aglycone of thevetin B, was also identified using a semi-untargeted analysis. This is the first report of a quantitative determination of cardiac glycosides of yellow oleander in blood and urine. The finding may support very early administration of activated charcoal to possibly prevent further formation of secondary, and possibly more potent, glycosides and limit toxicity.
黄花夹竹桃含有类似地高辛的强心苷,在斯里兰卡和印度经常导致中毒。然而,迄今为止,尚未通过分析确认有相关接触情况,也从未对人体生物体液中的植物特定苷进行过定量测定。我们报告了意大利一名年轻女性的罕见自服中毒病例,她摄入了9颗碾碎的黄花夹竹桃种子,心电图显示二度房室传导阻滞,随后被送往急诊室。该病例采用活性炭、重复剂量的抗地高辛免疫Fab及支持性治疗。出现了短暂性血小板减少,并在数天内消退。采用超高效液相色谱-串联质谱法测定和定量血浆及尿液中的黄夹苷A、黄夹苷B和秘鲁苷。种子中的两种主要苷黄夹苷A和黄夹苷B在所有样本中均未检出,而在第1天和第3天的所有生物样本中均检测到了代谢产物秘鲁苷的可检测水平。还通过半非靶向分析鉴定出了黄夹苷B的苷元洋地黄毒苷元。这是首次对血液和尿液中黄花夹竹桃强心苷进行定量测定的报告。这一发现可能支持尽早给予活性炭,以可能防止进一步形成次生的、可能更具效力的苷并限制毒性。